Tech Company Financing Transactions
Zosano Pharma Funding Round
HBM Healthcare Investments and New Enterprise Associates participated in a $75 million funding round for Zosano Pharma. The round was recorded on 12/31/2006.
Transaction Overview
Company Name
Announced On
12/31/2006
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Undisclosed
Investors
New Enterprise Associates (James Barrett)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
34790 Ardentech Ct.
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Overview
Zosamo Pharma (NASDAQ: ZSAN) is a specialty pharmaceutical company focused on the development of novel proprietary products via the Macroflux technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Walker
Chief Financial Officer
Gregory Kitchener
Chief Medical Officer
Donald Kellerman
VP - Operations
Hayley Lewis
Browse more venture capital transactions:
Prev: 12/31/2006: FilmFree Entertainment venture capital transaction
Next: 12/31/2006: Workday venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs